Cordlife Group (SGX:P8A) 3-Year EBITDA Growth Rate : -11.10% (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Cordlife Group 3-Year EBITDA Growth Rate?

Cordlife Group's EBITDA per Share for the six months ended in Dec. 2023 was S$0.02.

During the past 12 months, Cordlife Group's average EBITDA Per Share Growth Rate was -8.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -11.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 12.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -9.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Cordlife Group was 51.80% per year. The lowest was -54.90% per year. And the median was -10.40% per year.

Competitive Comparison of Cordlife Group's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Cordlife Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cordlife Group's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cordlife Group's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Cordlife Group's 3-Year EBITDA Growth Rate falls into.

Cordlife Group 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Cordlife Group (SGX:P8A) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Cordlife Group 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Cordlife Group's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Cordlife Group (SGX:P8A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cordlife Group Ltd (SGX:P8A) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

CLIFF:USA

Address

1 Yishun Industrial Street 1, Number 06-01/09, A'Posh Bizhub, Singapore, SGP, 768160

Website

https://www.cordlife.com

Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Cordlife has processing and storage facilities in six key markets across Asia, namely Singapore, Hong Kong, Malaysia, India, Indonesia, and the Philippines. The company has two segments - The Banking segment, comprises cord blood, cord lining, and cord tissue services. The Diagnostics segment comprises Metascreen, which is a non-invasive metabolic screening test specially designed for newborn babies, non-invasive prenatal testing service and Eyescreen, a paediatric eye-screening service.

Cordlife Group (SGX:P8A) Headlines

No Headlines